Repository logo
 

Indian Journal of Research in Homoeopathy

Permanent URI for this collectionhttps://aoh.ccrhlibrary.in/handle/123456789/38

Browse

Subject: search.filters.subject.Phosphorus

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Individualised homoeopathic treatment of paranoid schizophrenia with potentised Phosphorus
    (Central Council for Research in Homoeopathy, 2025) Bhuvaneswari, R; Sakthivel, Vaiyapuri
    Background: Paranoid schizophrenia is a severe mental disorder that affects approximately one percent of the world population, with devastating consequences for affected individuals and their families. Homoeopathy could be an effective alternative mode of treatment and can minimise the consequences of it. This case report aimed to highlight the significance of using only individualised homoeopathic medicines in the treatment of paranoid schizophrenia without conventional medicine. Case Summary: A 30-year-old male complained of someone controlling his mind, someone talking about him. He was suspicious of the food he was served, talked and laughed to himself and slept insufficiently. The case was diagnosed as paranoid schizophrenia by the psychiatrist. The severity of the disease was measured by the Positive and Negative Syndrome Scale (PANSS) and assessment of the positive symptoms was done by Scale for the Assessment of Positive Symptoms (SAPS); the symptoms were recorded at the baseline and every month for the duration of 17 months, with the help of the psychiatrist. Phosphorus 30C was prescribed on the basis of individualisation. No homoeopathic aggravation was reported during the treatment. PANSS score of 84 at baseline reduced to 32 and SAPS score of 56 reduced to zero, within ten months of treatment and remained so for up to 17 months, including the period of observation. MONARCH score of +8 indicated a causal attribution of homoeopathic treatment to disease improvement.
  • Thumbnail Image
    Item
    Role of homoeopathic treatment for symptom management and improving quality of life in severe psoriatic disease
    (Central Council for Research in Homoeopathy, 2025) Das, Kapil; Pal, Gautam
    Introduction: Psoriasis and Psoriatic Arthritis (PsA) are the main phenotypes of psoriatic disease. PsA is a chronic inflammatory arthritis, associated with psoriasis that can cause joint damage and can severely impact a patient’s quality of life (QoL). Case Summary: A 21-year old male suffering from PsA for three years presented in the outpatient department. He was previously treated with different methods of treatment without much relief. Clinically along with psoriatic rash, patient reported swelling, pain and stiffness of joints, causing restriction of movement. In addition, patient also presented with ophthalmic and gastric complaints. After a thorough clinical evaluation, Phosphorus in increasing potency (up to 0/12), was prescribed during one year of follow-up. The impact of the disease and its treatment on QoL and the outcome were assessed using tools such as Psoriasis Area and Severity Index (PASI), and PsA impact of disease-12 (PsAID12). The Modified Naranjo Criteria for Homoeopathy inventory score was also used to assess the possible causal attribution between the treatment and outcome. This case report demonstrates a remarkable improvement of patient’s presenting complaints as well as the improvement in both PASI and PsAID12 scores with individualised homoeopathic treatment.